These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 8719897)
1. Type III procollagen N-peptide correlates with beta-2-microglobulin in myelomatosis. Hasselbalch HC; Bjerrum OW; Junker P Clin Lab Haematol; 1995 Sep; 17(3):237-41. PubMed ID: 8719897 [TBL] [Abstract][Full Text] [Related]
2. Urinary amino-terminal propeptide of type III procollagen (PIIINP) as a marker of interstitial fibrosis in renal transplant recipients. Teppo AM; Törnroth T; Honkanen E; Grönhagen-Riska C Transplantation; 2003 Jun; 75(12):2113-9. PubMed ID: 12829921 [TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of laminin P1 and aminoterminal propeptide of type III procollagen in sickle cell disease. Bolarin DM; Swerdlow P; Wallace AM; Littsey L Haematologia (Budap); 1998; 29(1):51-8. PubMed ID: 9704258 [TBL] [Abstract][Full Text] [Related]
4. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen. Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813 [TBL] [Abstract][Full Text] [Related]
5. Serum aminoterminal propeptide of type III procollagen. A non-invasive test for liver fibrogenesis in methotrexate-treated psoriatics. Zachariae H; Søgaard H; Heickendorff L Acta Derm Venereol; 1989; 69(3):241-4. PubMed ID: 2566230 [TBL] [Abstract][Full Text] [Related]
6. [Serum beta 2-microglobulin in multiple myeloma. II. Its significance in monitoring the disease]. Scudla V; Budíková M; Fischerová E; Raska I; Vavrdová V Vnitr Lek; 1991 May; 37(5):479-87. PubMed ID: 1842146 [TBL] [Abstract][Full Text] [Related]
7. Serial determinations of aminoterminal propeptide of type III procollagen (PIIINP) and prognosis in ovarian cancer; comparison to CA125. Simojoki M; Santala M; Risteli J; Risteli L; Kauppila A Anticancer Res; 2000; 20(6C):4655-60. PubMed ID: 11205196 [TBL] [Abstract][Full Text] [Related]
9. [Clinical usefulness of serum beta2-microglobulin determination in patients with multiple myeloma]. Kraj M; Maj S; Pogłód R; Rostkowska J Acta Haematol Pol; 1989; 20(2):140-51. PubMed ID: 2700533 [TBL] [Abstract][Full Text] [Related]
10. Propeptide levels of procollagen type IV (NC1) and III (PIIINP) in patients undergoing haemodialysis. Keller F; Dingeldein K; Ser YL; Schuppan D Int Urol Nephrol; 1993; 25(3):305-8. PubMed ID: 8225832 [TBL] [Abstract][Full Text] [Related]
11. Analytical, physiologic, and clinical validation of a radioimmunoassay for measurement of procollagen type III amino terminal propeptide in serum and bronchoalveolar lavage fluid obtained from dogs. Schuller S; Valentin S; Remy B; Jespers P; Foulon S; Van Israël N; Clercx C; McEntee K Am J Vet Res; 2006 May; 67(5):749-55. PubMed ID: 16649905 [TBL] [Abstract][Full Text] [Related]
13. Unexpected normal serum beta-microglobulin (B2M) levels in multiple myeloma. Bataille R; Grenier J; Sany J Anticancer Res; 1987; 7(3 Pt B):513-5. PubMed ID: 3307602 [TBL] [Abstract][Full Text] [Related]
14. Amino-terminal propeptide of type III procollagen: a new prognosis indicator in human ovarian cancer. Kauppila A; Puistola U; Risteli J; Risteli L Cancer Res; 1989 Apr; 49(7):1885-9. PubMed ID: 2924328 [TBL] [Abstract][Full Text] [Related]
15. The aminoterminal propeptide of type III procollagen. Studies on physiology and pathophysiology. Jensen LT Dan Med Bull; 1997 Feb; 44(1):70-8. PubMed ID: 9062765 [TBL] [Abstract][Full Text] [Related]
16. Beta-2-microglobulin levels in patients with extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type: a retrospective analysis. Penz MZ; Fiebiger WC; Valencak JB; Osterreicher C; Ba-Ssalamah A; Formanek M; Brodowic T; Chott A; Raderer M Anticancer Res; 2001; 21(4B):3049-52. PubMed ID: 11712809 [TBL] [Abstract][Full Text] [Related]
17. Monitoring of multiple myeloma and bone marrow fibrosis with aminoterminal propeptide of type III collagen (PIIINP). Taube T; Franssila K; Risteli L; Risteli J; Elomaa I Br J Haematol; 1992 Sep; 82(1):32-7. PubMed ID: 1419800 [TBL] [Abstract][Full Text] [Related]
18. Biochemical markers of types I and III collagen and limited joint mobility in type 1 diabetic patients. Arkkila PE; Koskinen PJ; Kantola IM; Rönnemaa T; Seppänen E; Viikari JS Acta Diabetol; 2003 Dec; 40(4):151-5. PubMed ID: 14740273 [TBL] [Abstract][Full Text] [Related]
19. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin. Trocme C; Leroy V; Sturm N; Hilleret MN; Bottari S; Morel F; Zarski JP J Viral Hepat; 2006 Oct; 13(10):643-51. PubMed ID: 16970595 [TBL] [Abstract][Full Text] [Related]
20. Myocardial collagen turnover in normotensive obese patients: relation to insulin resistance. Quilliot D; Alla F; Böhme P; Bruntz JF; Hammadi M; Dousset B; Ziegler O; Zannad F Int J Obes (Lond); 2005 Nov; 29(11):1321-8. PubMed ID: 16116494 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]